Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 1845 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Director, Social Impact & Novartis Foundation (Japan) for the Promotion of Science Regular, Full time | Other | Japan | Toranomon (NPKK Head Office) | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regular (Sales), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Validation Lead (m/f/d) Regulär, Full time | Production / Manufacturing | Austria | Kundl | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regulär (Außendienst), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) 正式（销售）, Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Web Project Manager Regular, Full time | Marketing | Mexico | INSURGENTES | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regular (Ventas), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Redni sodelavec (prodaja), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Kadrolu (Satış), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regular (Sales), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
Adverse Event Reporting
We encourage using the following electronic reporting tool for reporting into the safety database directly: https://www.report.novartis.com/
If electronic reporting tool is not working – please use the following Generic mailbox: [email protected]
CISCO: +20 2 22861000: Press 3 for Adverse Event Reporting